These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22452623)

  • 41. The risk of malignant melanoma arising in congenital melanocytic nevi. An argument against the assignment of risk based on size alone.
    Rhodes AR
    Am J Dermatopathol; 1984; 6 Suppl():184-8. PubMed ID: 6528918
    [No Abstract]   [Full Text] [Related]  

  • 42. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
    Gerami P; Paller AS
    J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melanoma arising in a child with a medium-sized congenital melanocytic nevus.
    Montes MV; Castro C; Anaya J; Steinberg D; Busso C
    Medicina (B Aires); 2024; 84(5):1002-1006. PubMed ID: 39399944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk estimation for malignant transformation of melanocytic nevi.
    Bauer J; Garbe C
    Arch Dermatol; 2004 Jan; 140(1):127; author reply 127. PubMed ID: 14732675
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.
    Cesinaro AM; Natoli C; Grassadonia A; Tinari N; Iacobelli S; Trentini GP
    J Invest Dermatol; 2002 Jul; 119(1):187-90. PubMed ID: 12164944
    [No Abstract]   [Full Text] [Related]  

  • 46. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
    Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
    Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between melanocytic nevi and malignant melanoma.
    Friedman RJ; Rigel DS; Heilman ER
    Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant melanoma arising from giant congenital melanocytic nevus with SMARCA2 gene mutation.
    Xie Y; Zhou Z; Deng D; Liu Y
    Asian J Surg; 2024 Jul; 47(7):3320-3321. PubMed ID: 38604858
    [No Abstract]   [Full Text] [Related]  

  • 49. Significant melanocytic lesions in infancy, childhood, and adolescence.
    Hoss DM; Grant-Kels JM
    Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Melanoma in congenital melanocytic naevi.
    Kinsler VA; O'Hare P; Bulstrode N; Calonje JE; Chong WK; Hargrave D; Jacques T; Lomas D; Sebire NJ; Slater O
    Br J Dermatol; 2017 May; 176(5):1131-1143. PubMed ID: 28078671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanoma Gene Expression Markers for Surveillance of Epidermolysis Bullosa Nevi Malignant Transformation.
    Ahn JW; Johnson K; Kohen LL; Chaffins ML; Shwayder T
    JAMA Dermatol; 2016 May; 152(5):584-6. PubMed ID: 26865206
    [No Abstract]   [Full Text] [Related]  

  • 52. Nodal melanocytic nevus with balloon-cell change (nodal balloon-cell nevus).
    Urso C
    J Cutan Pathol; 2008 Jul; 35(7):672-6. PubMed ID: 18312441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings.
    Machan S; Molina-Ruiz AM; Fernández-Aceñero MJ; Encabo B; LeBoit P; Bastian BC; Requena L
    Am J Dermatopathol; 2015 Jun; 37(6):487-94. PubMed ID: 25062263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant transformation in giant congenital pigmented nevus. Death in early childhood.
    Penman HG; Stringer HC
    Arch Dermatol; 1971 Apr; 103(4):428-32. PubMed ID: 5091867
    [No Abstract]   [Full Text] [Related]  

  • 55. Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi.
    Aimaier R; Chung M; Zhu H; Yu Q
    Exp Dermatol; 2022 Apr; 31(4):582-585. PubMed ID: 35020224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
    García-Casado Z; Traves V; Bañuls J; Niveiro M; Gimeno-Carpio E; Jimenez-Sanchez AI; Moragón M; Onrubia JA; Oliver V; Kumar R; Nagore E
    Br J Dermatol; 2015 Apr; 172(4):1128-31. PubMed ID: 25385688
    [No Abstract]   [Full Text] [Related]  

  • 57. Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
    de Jel MM; Engelmann JC; Kunz M; Schiffner S; Kuphal S; Bosserhoff AK
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):678-80. PubMed ID: 24661573
    [No Abstract]   [Full Text] [Related]  

  • 58. Dermoscopy of melanocytic neoplasms: familial patterns.
    Grichnik JM
    Arch Dermatol; 2004 May; 140(5):642. PubMed ID: 15148119
    [No Abstract]   [Full Text] [Related]  

  • 59. Pluripotential melanoblastoma, a unifying concept on malignancies arising in congenital melanocytic nevi: report of two cases.
    Cohen MC; Kaschula RO; Sinclair-Smith C; Emms M; Drut R
    Pediatr Pathol Lab Med; 1996; 16(5):801-12. PubMed ID: 9025878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic.
    Urso C
    Am J Dermatopathol; 2007 Oct; 29(5):491-4. PubMed ID: 17890925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.